Nalmefene Hydrochloride Injectable Solution

Form: Injectable Solution

Strength: 1 mg/mL in 1 mL or 2 mL vials

Reference Brands: Selincro(EU)

Category: Antipsychotropic Drugs

Nalmefene Hydrochloride Injectable Solution is approved in the USA by the FDA and in the EU under EMA guidelines for the emergency treatment of known or suspected opioid overdose. In the U.S., it is marketed under brand names such as Revex®, while in Europe, it is authorized under strict prescription-only status. Nalmefene’s rapid onset and longer duration of action make it particularly valuable in opioid reversal scenarios, especially in fentanyl-related cases. Manufacturers must comply with cGMP regulations, pharmacovigilance standards, and secure labeling practices. Explore Nalmefene formulations and other opioid antagonists at Pharmatradz.com – your trusted B2B pharma platform.